What is PharmaSynergy OTC?
PharmaSynergy OTC is a partnering event for pharma BD & distribution executives focused on OTC/CHC products.
In addition to partnering meetings, PharmaSynergy OTC offers an engaging and informative agenda that delves into the latest industry trends and analytics, successful commercial strategies, and growth drivers, highlighting opportunities in growth markets.
PharmaSynergy OTC runs product-focused B2B partnering meetings specifically designed for companies with portfolios in:
#Nutraceuticals & #FSMP
#Dermocosmetics / #medical_cosmetics
How Does B2B Partnering Work?
2023 Speaker Lineup Featured
Head of Sales Consumer Healthcare, CINFA
Founder and CEO, Maxwellia
Head of Global Consumer Healthcare Franchise, Chiesi Group
Vice President, Consumer Health, IQVIA
Global Director New Category, Essity
Head of Business Development Health & Wellness Brands, Alibaba Group
Head of Business Development and Marketing, Europe & Middle East, Aspen Pharma Europe
Miguel Mutti Co-Founder & Managing Partner, Sin&rgetica
Healthcare Business Development, Emerging Markets, Modern Pharmaceutical
Founder, Maestro Consulting
Head of Global OTC Pharma Business Development, Weleda
Consultant, Euromonitor International
Business Development Director, PharmaLinea
Regional Country Manager, APAC, Luye Pharma International
Dr. Francesco Di Pierro
President of the Microbiota International Clinical Society, Scientific Director, PharmExtracta
Company Owner, GEMIL Pharma
CEO & Co-founder, Metis Healthcare
2023 PharmaSynergy - OTC Programme
A key value-added feature of the PharmaSynergy-OTC event is its professional and tailored content, designed to meet the specific needs and interests of our audience. We strive to offer not only interesting topics and real cases but also content that is inspiring and actionable for all attendees.
During the upcoming event in Milan in September, we discussed a wide range of relevant subjects, including:
- Global analytics and consumer insights
- Innovations in the OTC/CHC industry
- Rx-to-OTC switch strategies
- Strategic portfolio growth in the pharmaceutical sector
- Commercial excellence practices
- Global markets and partnership opportunities
- Add-on therapy projects in the nutraceutical space